Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP

Dr Marianne Davies is a graduate of Yale University School of Nursing (MSN-Oncology Clinical Nurse Specialist and Post-Masters Acute Care Nurse Practitioner) and MGH Institute of Health Professions (DNP and Certificate of Teaching and Learning). She is an assistant professor of nursing at the Yale School of Nursing, teaching in the Masters and Doctoral programs, and coordinator of the Oncology Nurse Practitioner Concentration. Dr. Davies holds a joint appointment at the Yale Comprehensive Cancer Center. She has been an oncology nurse practitioner in thoracic medical oncology for several years. Her area of specialization is on clinical trials of immunotherapy agents, targeted therapies, and new drug development. Dr. Davies pursues a specific concentration on the management of toxicities associated with immune and targeted therapeutics. She is Co-chair of the Yale New Haven Hospital Advanced Practice Nurse Council. She is a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO), Oncology Nursing Society (ONS), International Association for the Study of Lung Cancer (IASLC), International Thoracic Oncology Nursing Forum (ITONF), Society for Immunotherapy of Cancer (SITC), and Association of Community Care Centers Institute for Clinical Immuno-Oncology (ICLIO). She serves on the Immunotherapy Guideline Development Boards of the Society of Immunotherapy of Cancer and the National Comprehensive Cancer Network. She has published and presented extensively on the topics of lung cancer, immunotherapy, targeted therapy, and symptom management.

Leave a reply